884500-82-7

Usage

Uses

Used in Pharmaceutical Industry:
4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)is used as a bioactive agent for the development of new drugs or therapeutics. Its unique structural features and potential pharmaceutical applications make it a promising candidate for further research and development in the pharmaceutical industry.
Used in Scientific Research:
4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)is used as a subject of interest for researchers and chemists in various fields of science and medicine. Its unique structural features and potential applications make it a valuable compound for further investigation and exploration of its properties and uses.

InChI:InChI=1/C15H11NO3/c1-18-11-6-4-10(5-7-11)14-9-13(17)12-3-2-8-16-15(12)19-14/h2-9H,1H3

Upstream product

• 40134-18-7 methyl 2-chloropyridine-3-carboxylate 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 1301225-28-4 C₁₅H₁₂ClNO₃ 
• 67367-26-4 2-methoxynicotinic acid methyl ester 
• 1452-94-4 ethyl 2-chloronicotinate 
• 884501-75-1 1-(4-methoxyphenyl)-3-(2-methoxypyridin-3-yl)propane-1,3-dione 

Relevant academic research and scientific papers

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer as well as sepsis

Transition-metal-free intramolecular Ullmann-type O-arylation: Synthesis of chromone derivatives

(Chemical Equation Presented) Expect the upexpected: A transition-metal- free approach to access chromone derivatives has been developed. The intramolecular O-arylation of substituted 1-(2-haloaryl)-propane-1,3-diones in DMF in the presence of K2CO3 gave the corresponding target products in good to excellent yields (see scheme; DMF = N,N′- dimethylformamide).

PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES

The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.